Similarly, RANK signaling seems to increase after menopause in breast tumors, as multiple pathways related to NFKB activation, including RANKL pathway, were positively associated with RANK protein expression only in postmenopausal patients. This evidence concerns the gene NFKB1 and breast neoplasm.